Cargando…
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
BACKGROUND: Osteosarcoma is a rare malignant bone tumor in adolescents and children. Poor prognosis has always been a difficult problem for patients with osteosarcoma. Recent studies have shown that tumor infiltrating immune cells (TIICs) are associated with the clinical outcome of osteosarcoma pati...
Autores principales: | Chen, Ying, Zhao, Bo, Wang, Xiaohu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579940/ https://www.ncbi.nlm.nih.gov/pubmed/33087099 http://dx.doi.org/10.1186/s12885-020-07536-3 |
Ejemplares similares
-
Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma
por: He, Zhengxi, et al.
Publicado: (2022) -
RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
por: Chen, Shijie, et al.
Publicado: (2022) -
PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
por: Yao, Feng, et al.
Publicado: (2021) -
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma
por: Yang, Bingsheng, et al.
Publicado: (2021) -
A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
por: Chen, Pengyu, et al.
Publicado: (2023)